How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

GR

NASDAQ:GRNA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

GR

Greenlight Biosciences Holdings PBCNASDAQ GRNA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is GRNA undervalued compared to its fair value?

The fair value of GRNA stock is hidden USD. Relative to the market price of 0 USD Greenlight Biosciences Holdings PBC is hidden.

GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. The company is headquartered in Medford, Massachusetts. The compan...[More about valuation]

Greenlight Biosciences Holdings PBC Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.045 $B

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.188

FINANCIALS

Greenlight Biosciences Holdings PBC financial for reporting period

Income Statement

0.0038 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.028 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.028 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0038 B 100%
-0.028 B -741%
-0.028 B -745%

Balance Sheet

0.11 B
0.022 B

0.025 B

Financial Position Analysis

Assets

0.11 B
Current Assets
0.038 B
Total non-current assets
0.076 B

Total current liabilities
0.031 B
Total non-current liabilities
0.061 B

Cash Flow Statement

-0.036 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.031 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Greenlight Biosciences Holdings PBC fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-374 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-371 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-123 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is GRNA attractive for investment based on fundamental analysis?

GRNA stock rating is hidden. Greenlight Biosciences Holdings PBC is a hidden by Eyestock methodology.

Get GRNA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-1 521

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

1.829

Debt / Equity ratio:

0.675

ROE:

-374

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

GRNA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for GRNA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Greenlight Biosciences Holdings PBC competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Greenlight Biosciences Holdings PBC dividends

GRNA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About GRNA stock

About the company Greenlight Biosciences Holdings PBC

Market cap $B

0.045

Dividend yield

Shares outstanding

151.552 B

GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. The company is headquartered in Medford, Massachusetts. The company went IPO on 2021-01-14. The firm is focused on Ribonucleic acid (RNA) research, design, and manufacturing for human, animal, and plant health. The firm has developed technology to create high-performing, natural ribonucleic acid (RNA) products to address global sustainability challenges and promote healthier plants, foods, and people. The firm is engaged in the cell-free biomanufacturing platform. This platform enables the making of complex biological molecules nucleic acids, peptides, carbohydrates, and many others which allows manufacturing products at a lower cost than traditional methods using fermentation. The platform is used to develop and commercialize products. The firm's pipeline for plant and animal health includes Colorado potato beetle, Botrytis cinerea, Varroa mites, Fungicides, Grapevine powdery mildew, Fusarium Head Blight (FHB), Lepidoptera, and Powdery mildew.

GRNA profile

  • Ticker

    GRNA

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    14 January 2021

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    312

  • City

    Medford

  • Address

    200 Boston Avenue, Suite 3100

  • Cusip

    39536G105